AzarGen And iBio Push On With Plant-Based Rituximab

Biosimilar Development Aimed Towards African Continent

 
• By Dean Rudge
  
Plants_Biochemistry
AzarGen and iBio signed a master joint development agreement two years ago • Source: Shutterstock

More from Biosimilars

More from Products